Rosuvastatin and retinoic acid may act as ‘pleiotropic agents’ against β-adrenergic agonist-induced acute myocardial injury through modulation of multiple signalling pathways
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 318, 108970
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 75 references indexed in Scilit:
- Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic AntioxidantsOxidative Medicine and Cellular Longevity, 2013
- Nrf2and Cardiovascular DefenseOxidative Medicine and Cellular Longevity, 2013
- An Update on CardioprotectionJACC, 2012
- Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulationBritish Journal of Pharmacology, 2006
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Up-Regulation of Endothelial Nitric Oxide Synthase through β2-Adrenergic Receptor—The Role of a β-Blocker with NO-Releasing ActionBiochemical and Biophysical Research Communications, 2001
- Adrenaline-induced “oxygen-wastage” and enzyme release from working rat heart. Effects of calcium antagonism, β-blockade, nicotinic acid and coronary artery ligationJournal of Molecular and Cellular Cardiology, 1979